WeChat
Visit
18584071867

ABOUT US

Company profile

Chengdu Huitai Biomedicine Co., Ltd., founded on January 22, 2017, located in Tianfu Life Science Park, Chengdu High-tech Zone, the Southwest of China,is an anti-fibrotic biotech company with global first-in-class therapeutics.
MORE >
R&D Pipeline

R&D pipeline

At present, the developing novel drug for the treatment of Idiopathic Pulmonary Fibrosis (IPF) is targeted regulation of TGF-β signaling, and there is no similar competitive product in the world. The drug has now completed the pre-clinical research (GMP production and GLP safety assessment), and we are going to submit the application of first-in-c...

Science and Technology

News Center
Development

Talent first, welcome to huitai home。

企业核心价值观 Our core values

人才第一 talent and capacity

诚信利他 Honesty and altruism

专业精准 Profession and accuracy

协作赋能 Cooperation and empowerment

奋斗共赢 Loyalty and mutual-benefit